Epstein-Barr virus is not associated with head and neck neoplasms other than nasopharyngeal carcinoma
Kottaridis, S.D.; Goula, I.; Kiparissiadis, P.
Neoplasma 29(3): 327-331
1982
ISSN/ISBN: 0028-2685 PMID: 6290911 Document Number: 189591
Document emailed within 1 workday
Related Documents
Friborg, J.T.; Melbye, M. 2002: Epstein-Barr virus and nasopharyngeal carcinoma Ugeskrift for Laeger 164(50): 5908-5911Furukawa, M. 1990: Epstein-Barr virus (EBV) infection associated with nasopharyngeal carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(4 Part 1): 601-607
Glaser, R.; Stoerker, J.; Cheng, Y.C. 1983: The association of Epstein-Barr virus with nasopharyngeal carcinoma Progress in Clinical and Biological Research 132b: 49-59
Zheng, Y.-M.; Cain, Y.-L.; Cheng, J.-R.; Li, J.; Mo, Y.-K.; Gao, J.-Q.; Dong, Z.-R.; Zhong, Q.-Y. 2009: Evaluation of detection of Epstein-Barr virus Rta/IgG in nasopharyngeal carcinoma Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(4): 285-287
Budiani, D.R.; Hutahaean, S.; Haryana, S.M.; Soesatyo, M.H.N.E.; Sosroseno, W. 2002: Interleukin-10 levels in Epstein-Barr virus-associated nasopharyngeal carcinoma Journal of Microbiology Immunology and Infection 35(4): 265-268
Tung, Y.C.; Lin, K.H.; Chu, P.Y.; Hsu, C.C.; Kuo, W.R. 1999: Detection of human papilloma virus and Epstein-Barr virus DNA in nasopharyngeal carcinoma by polymerase chain reaction Kaohsiung Journal of Medical Sciences 15(5): 256-262
Akao, I.; Sato, Y.; Mukai, K.; Sugano, S.; Hoshikawa, T.; Suzuki, T.; Tsutsumi, K. 1996: Localization of Epstein-Barr virus in lymph node metastasis with nasopharyngeal carcinoma Acta Oto-Laryngologica. Supplementum 522: 86-88
Lynn, T.C.; Hsu, M.M.; Hsieh, T.; Tu, S.M.; Hamajima, K. 1976: Nasopharyngeal carcinoma and Epstein-Barr virus. III. the detection of anti-nuclear antibodies Japanese Journal of Experimental Medicine 46(5): 289-295
Klein, G. 1977: Epstein-Barr virus, infectious mononucleosis, Burkitt's lymphoma and nasopharyngeal carcinoma Israel Journal of Medical Sciences 13(7): 716-724
Desgranges, C.; de-Thé, G.; Wolf, H.; zur Hausen, H. 1975: Further studies on the detection of the Epstein-Barr virus DNA in nasopharyngeal carcinoma biopsies from different parts of the world Iarc Scientific Publications 1975(11 Part 2): 191-193
Friedrich, R.E.; Bartel-Friedrich, S.; Lobeck, H.; Niedobitek, G.; Arps, H. 2000: Epstein-Barr virus DNA, intermediate filaments and epithelial membrane antigen in nasopharyngeal carcinoma Anticancer Research 20(6d): 4909-4916
Yang, C.S.; Ou, Y.H.; Cho, S.M.; Hsu, T.Y.; Liu, M.Y.; Huang, T.S.; Chen, J.Y. 1991: Analysis of Epstein-Barr virus DNA in nude mouse-passaged nasopharyngeal carcinoma tissues Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 24(1): 95-107
Plaza, G.; Santón, A.; Fogué, L.; Bellas, C.; Martínez Vidal, A. 1999: Neck lymph node metastases of unknown origin: nasopharyngeal origin and EBV (Epstein-Barr virus) Acta Otorrinolaringologica Espanola 50(8): 623-629
Huang, H.; Pan, X.; Yu, L. 1998: The effect of Epstein-Barr virus gene BHRF1 expression on the apoptotic resistance of nasopharyngeal carcinoma cells Zhonghua Zhong Liu Za Zhi 20(4): 245-247
Nurhantari, Y.; Emoto, N.; Rahayu, P.; Matsuo, M. 2003: Nasopharyngeal carcinoma in Indonesia has a low prevalence of the 30-base pair deletion of Epstein-Barr virus latent membrane protein 1 Southeast Asian Journal of Tropical Medicine and Public Health 34(1): 98-105
Du, C.; Wen, B.; Li, D.; Lin, Y.; Zheng, Y.; Peng, X.; Hong, C.; Chen, J.; Lin, W.; Hong, X.; Xie, L.; Wu, M. 2006: Downregulation of Epstein-Barr virus-encoded latent membrane protein-1 by arsenic trioxide in nasopharyngeal carcinoma cells Tumori 92(2): 140-148
Luxamechanporn, T.; Neimhom, S.; Kunachak, S.; Kulapaditharom, B. 1999: Polymerase chain reaction study of Epstein-Barr virus in high risk group of nasopharyngeal carcinoma: a preliminary report Journal of the Medical Association of Thailand 82(6): 593-597
Simons, M.J.; Wee, G.B.; Chan, S.H.; Shanmugaratnam, K.; Day, N.E.; de-Thé, G. 1975: Immunogenetic aspects of nasopharyngeal carcinoma (NPC) III. HL-a type as a genetic marker of NPC predisposition to test the hypothesis that Epstein-Barr virus is an etiological factor in NPC Iarc Scientific Publications 1975(11 Part 2): 249-258
Brandes, L.J.; Goldenberg, G.J. 1974: In vitro transfer of cellular immunity against nasopharyngeal carcinoma using transfer factor from donors with Epstein-Barr virus antibody activity Cancer Research 34(11): 3095-3101
Yang, T.-t.; Wang, Y.; Liu, X.; Li, X.; Pang, Z.-c.; Luo, B. 2009: Genotyping of Epstein-Barr virus in Epstein-Barr virus associated gastric carcinoma Bing du Xue Bao 25(1): 29-34